SS
NUVB icon

Steve Schonfeld’s Nuvation Bio NUVB Stock Holding History

Steve Schonfeld’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-240,277
Closed -$550K – 2274
2024
Q3 		$550K Sell
240,277
-326,560
-58% -$996K ﹤0.01% 1392
2024
Q2 		$1.66M Buy
+566,837
New +$1.73M 0.01% 987
2023
Q2 		– Sell
-10,200
Closed -$16.9K – 2390
2023
Q1 		$16.9K Sell
10,200
-18,400
-64% -$37.3K ﹤0.01% 1843
2022
Q4 		$54.9K Sell
28,600
-22,400
-44% -$45.3K ﹤0.01% 2257
2022
Q3 		$114K Sell
51,000
-14,300
-22% -$40.8K ﹤0.01% 2514
2022
Q2 		$212K Buy
65,300
+1,700
+3% +$7.41K ﹤0.01% 1856
2022
Q1 		$335K Buy
+63,600
New +$357K ﹤0.01% 1622
2021
Q2 		– Sell
-17,386
Closed -$181K – 2186
2021
Q1 		$181K Buy
+17,386
New +$194K ﹤0.01% 1539

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Steve Schonfeld's NUVB Position: Q4 2024 in Review

Steve Schonfeld sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 240,277 shares — an estimated $550K sold.

Steve Schonfeld first reported a position in NUVB in Q1 2021 and held it in 8 quarters. The position peaked at $1.66M in Q2 2024. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Steve Schonfeld reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Steve Schonfeld sold 240,277 Nuvation Bio shares in Q4 2024, an estimated $550K.
  • Steve Schonfeld first reported a position in Nuvation Bio in Q1 2021 and held it in 8 quarters.
  • Steve Schonfeld's Nuvation Bio position peaked at $1.66M in Q2 2024.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.